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ABSTRACT
Background. Renal dysfunction is a serious 
problem and it provides a poor prognosis for 
patients with advanced liver cirrhosis. This 
condition can progress to kidney failure, which is 
known as hepatorenal syndrome. Cystatin C 
utilization as a marker of decreased kidney function 
in patients with liver cirrhosis has been widely 
proven. Data on how far the severity of liver 
cirrhosis can affect the decline in renal function has 
not been widely known. 
Objective. This study aimed is to verify 
correlation between the severity degree of the liver 
(Child Pugh/CP score) with levels of Cystatin C 
serum. 
Methods. This study was a cross sectional 
study. Population studied were patients with liver 
cirrhosis who visited the clinic of Gastroentero-
hepatology and treated in the Department of 
Internal Medicine ward Dr. Sardjito Hospital - 
Yogyakarta during October 2009 - March 2010. 
Data were analyzed with a computer; the analysis of 
the CP score correlation with increased levels of 
Cystatin C using Spearman correlation for data not 
normally distributed. 
Result. We found 48 research subjects 
during the month of October 2009 - March 2010. The 
subjects were 35 male (72.9%) and 13 female 
(27.1%) with average age 53.1 ± 11.9 years old. 
Subjects with CP-A were 9 patients (18.8%), CP-B 
were 14 patients (29.2%) and CP-C were 25 patients 
(52.1%). The range value of Cystatin C between CP 
class shows CP-A  0.7 - 0.97 mg/L, CP-B 0.7 - 0.49 
mg/L, and CP-C 0.7 – 2.49 mg/L (statistically 
significant difference with p <0.05). Liver cirrhosis 
patients who had Cystatin C levels <0.96 mg/L were 
22 patients (45.83%) and 26 patients (54.1%), had 
higher levels of Cystatin C> 0.96 mg/L. Child score 
was positively correlated to increased levels of 
Cystatin C (p= 0.000; r= 0.566) linear regression 
equation with Cystatin was = 0.37 + 0.08 * Child 
score (r square 0.32). 
Conclusion. This study concluded that the 
Child score had a moderate positive correlation with 
Cystatin C serum level. 
Key words: Liver Cirrhosis – Child Pugh score - 
Cystatin C
INTRODUCTION
Chronic liver disease and cirrhosis cause 
350,000 deaths annually in the United State of 
America (USA). Cirrhosis is the ninth leading cause 
of death in the USA and was responsible for 1.2% of 
all deaths. Patients who have liver cirrhosis aged 
between fifth and sixth decades. In Indonesia, with a 
total estimated population of 238,452,952 people, 
the number of people who suffer from liver cirrhosis 
2  is estimated about 350,666 . In Yogyakarta, the 
number of hospitalized patients with cirrhosis 
ranges from 4.1% of all patients treated in the 
3Internal Medicine ward by the year 2004 . 
Cirrhosis is the final process of liver cells 
injury that turned into a form of fibrosis and nodular 
regeneration in almost all liver cells. Cirrhosis is a 
serious disease and generally is irreversible and in 
the USA, it included 10 largest cause of death. 
Arising clinical signs are the result of liver cell 
dysfunction, and portal hypertension portosistemik 
4shortcut . 
Some of the scoring system used to assess 
the severity of the disease and determine the 
prognosis in patients with cirrhosis. Child Pugh (CP) 
score is based on the severity of disease according to 
the signs, symptoms and laboratory examination 
results, this score proved to be able to predict the 
5survival rate .
Various kinds of complications can occur in 
patients with liver cirrhosis. Hepato-renal syndrome 
(HRS) occurs in approximately 4 of 10,000 patients 
with heart disease, such as acute liver failure, liver 
cirrhosis, or alcoholic hepatitis. Reported mortality 
16
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rates from an HRS were greater than 95% with an 
6average survival less than two weeks .
Renal dysfunction is a serious problem in 
patients with advanced liver cirrhosis, where 
patients with liver cirrhosis accompanied by ascites 
can cause kidney failure, a condition known as 
7  Hepato-renal syndrome . The declined in renal 
function in patients with liver cirrhosis, showed a 
poor prognosis. A prospective cohort study prove 
that in patients with cirrhosis, HRS type I has median 
survival rates 1.7 weeks and only 10% of patients 
survive more than 10 weeks, while in HRS type II 
survival rate reached 50% in first 5 months and 20% 
8in the first .
Creatinine, based on calculation of filtration 
glomerolus showed limitations in predicting GFR in 
patients with cirrhosis. Creatinine clearance have a 
higher estimation in estimating true GFR up to 200% 
9  . Cystatin C (cys C), is a non-glycosylated 13 kDa 
protein that is expected to predict the decline in GFR 
in patients with cirrhosis. Cystatin C is not 
influenced by age and body mass so that the 
measurement of Cystatin C is recommended to 
detect renal insufficiency in patients with liver 
9  cirrhosis . Increased Cystatin C proved to have 
significant correlation to the decline glomerolus 
filtration rate (r -0.85, p <0.001) than creatinine (r -
0.32, p <0.05) in patients with liver cirrhosis. 
Calculation of Cystatin C in patients with cirrhosis 
of the liver is not affected by age or body mass index 
10  . A liver cirrhosis accompanied by ascites and 
normal creatinine levels, Cystatin C concentration 
calculation proved to be as a prognostic marker of 
11future occurrence of HRS .
Due to the nature of reversible renal 
dysfunction in patients with liver cirrhosis, on this 
occasion we want to know any correlation between 
Child score with the levels of Cystatin C in patients 
with liver cirrhosis, and factors that significantly 
influence to the worsening of kidney function, so 
hopefully with this knowledge we can prevent the 
occurrence of an HRS in patients with liver cirrhosis. 
METHODS
This study was a cross-sectional study, with 
the aims of determining whether there was a 
correlation between Child Pugh score with Cystatin 
C levels in the blood. This research was conducted in 
the gastroentero-hepatologist clinic and internal 
medicine ward of Dr. Sardjito Hospital Yogyakarta 
during October 2019 - March 2010. 
Target populations were those who suffer 
from liver cirrhosis who visited at Dr. Sardjito 
Hospital Yogyakarta. Inclusion criteria were: 
Patients with liver cirrhosis, aged 18 years or older, 
and signed inform consent. Exclusion criteria were: 
Patients with heart failure or cardiac cirrhosis, 
patients with renal failure, sepsis, hepatocellulare 
carcinoma, long-term steroid use, thyroid 
dysfunction, hypertension and diabetes mellitus.
Patients who meet inclusion and exclusion 
criteria underwent anamnesis, physical and 
laboratory examination (albumin, bilirubin, 
prothrombin time, creatinine, urea nitrogen, INR, 
Cystatin C) and liver ultrasound. Patients were 
divided into two groups: those with normal levels of 
Cystatin C <0.96 and those with higher levels of 
Cystatin C> 0.96 and then we measured the factors 
that relate to differences in the levels of Cystatin. 
Data were analyzed with a computer; we analyze the 
child score correlation with increased levels of 
Cystatin C using the Pearson correlation for 
normally distributed data and Spearman correlation 
for data not normally distributed. 
RESULTS
During six months of research, 48 patients 
(male 72.9% and female 27.1%) who met the criteria 
for exclusion or inclusion were enrolled in the study. 
Based on Child criteria, there were 9 patients 
(19.8%) with Child A, 14 patients (29.2%) with 
Child B, and 25 patients (52.1%) with Child C. The 
average score of Child was 9.56  ± 2.7 and the 
average of age was 53.1 ± 11.9 years old. Most of the 
subjects had history of Hepatitis B (23 patients; 
47,0%)
Table 1.  Baseline characteristics of 
subjects (total subjects 48)
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Table 3. Child score component 
relationships and Cystatin C levels
In table 3, shows correlation between 
factors (components) in CP criteria to the level of 
Cystatin C (p: 0.000; r: 0.566). Albumin, total 
bilirubin and INR have a correlation of the levels of 
Cystatin C with the p value was significant (p 
<0.05). Levels of albumin with higher levels of 
Cystatin C had a weak negative correlation. Total 
bilirubin levels with higher levels of Cystatin C had 
a positive correlation (r: 0.501). INR levels with 
levels of Cystatin C had a strong positive correlation 
(r: 0.622).
Table 4. Multivariate analysis of liner-
related factors
From the scatter plot diagram, we obtained 
linear equations of Cystatin = 0.37 + 0.08 * Child 
Score with R-Square 0.32. After using multivariate 
analysis on serum albumin, bilirubin total INR and 
the degree of encephalopathy (table 4), note that the 
total bilirubin level and INR were the two factors 
most associated with elevated levels of Cystatin C, 
with linear equation = 0.82 + 0.04 * + 0.08 * total 
bilirubin INR (adjusted r square 51.8%).
DISCUSSION
In this study, we found the prevalence of 
child C liver cirrhosis to be more frequent than other 
groups 25 (52.1%) people. This is possible because 
the sampling was done at the hospital. Previous 
research conducted at the hospital about the 
mortality of patients based on the degree of severity 
of liver found the number of patients with Child C 
11liver cirrhosis who were treated as much as 54% .
The number gender shows males more than 
females (72.9% vs.27.1%). This was almost similar 
to a study conducted in Mexico, where the number 
of patients who underwent liver cirrhosis reached 
25% of the total patients admitted in internal 
12medicine, with the proportion of male - female 3: 1 . 
The role of gender on the incidence of liver cirrhosis 
has some differences based on the etiology and age. 
Liver cirrhosis caused by alcohol makes a 
comparison male – female range from 1.5 to 3:1, 
whereas in primary billiary cirrhosis in women has a 
higher incidence. In liver cirrhosis caused by viral 
infection, a comparison of men and women at age 
less than 35 years and more than 65 years had no 
significant difference, but at age 35-65 years the 
number of men who suffer from cirrhosis of the liver 
caused by previous hepatitis virus infection is higher 
than women 3 to 4 : 1. This is apparently due to the 
influence of estrogen in women who have a 
protective effect against the occurrence of liver 
13  cirrhosis . The average of age with cirrhosis in this 
study were 53.1±11.9 years.  Based on 
epidemiological data, cirrhosis of the liver is usually 
suffered by those who entered the age of five or six 
decade. 
Patients with a history of liver cirrhosis with 
hepatitis B, the most widely encountered in this 
study were as many as 47.9%. This result is similar 
to a study conducted in Ghana on the prevalence of 
viral hepatitis among patients with liver cirrhosis. In 
their study, they found the prevalence of positive 
HBsAg was 42.9%, where OR for the occurrence of 
cirrhosis 8.07 (p: 0.000). HCV is responsible for 
7.1% of cases with liver cirrhosis but not proved the 
The range value of Cystatin C between CP 
class shows CP-A  0.7 - 0.97 mg/L, CP-B 0.7 - 0.49 
mg/L, and CP-C 0.7 – 2.49 mg/L (statistically 
significant difference with p <0.05) (Figure 1). To 
know the correlation between the degrees of 
severity of the liver to the decline of renal function 
we performed regression analysis as seen in scatter 
diagram on figure 2. 
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existence of a significant relationship between the 
14incidence of cirrhosis itself .
Cystatin C levels increased above normal 
values, obtained in liver cirrhosis Child B. In 
previous studies, elevated levels of Cystatin C 
already observed in Child A, although the increment 
was not significant. Elevated levels of Cystatin C 
were more common in those with Child B and C, 
where the increasing in Child C was significantly 
15  higher .
Seo et al. (2009) found that Cystatin C 
concentration is a predictive factor for the incidence 
of HRS. In this study, the patients with liver cirrhosis 
with ascites and normal creatinine where all 
cirrhotic patients with Child B and C. In our 
research, elevated levels of Cystatin C were related 
with degrees of severity. Increased Cystatin C in our 
study started in Child B liver cirrhosis. After 
multivariate analysis with backward method, the 
levels of bilirubin and INR were factors that 
influence the increase in Cystatin C. Evidence that 
the degree of severity of the liver associated with 
elevated levels of Cystatin C can be seen in previous 
studies, which showed an average concentration 
levels of Cystatin C was higher in patients with 
hepatocellular carcinoma patients (1.16±0.1 mg/L) 
compared to patients with liver cirrhosis and 
patients with chronic hepatitis (1.13±0.09 mg/L and 
0.68±0.03 mg/L). Cystatin C concentration was also 
shown to have a correlation with histological degree 
of liver fibrosis stage and levels of total bilirubin, 
16albumin, and platelets . Increased bilirubin and 
INR showed increasing degrees of severity of liver. 
A previous study in patients with primary biliary 
cirrhosis found that levels of bilirubin and 
hyaluronic acid are the two independent variables 
associated with the degree of fibrosis in liver 
cirrhosis. Increased serum bilirubin of 10 mg/dl led 
to increased probability of the widespread degree of 
17cirrhosis by 3.4-fold (p: 0.05, CI 1.0 to 11.2) .
An elongated period of bleeding in patients 
with liver cirrhosis is a reflection of the severity of 
cirrhosis. Elevated levels of bilirubin as a marker of 
the severity of liver shows strong correlation with 
the length of bleeding (ß coefficient 0.19, p = 0.007) 
18.
CONCLUSIONS
Based on the results of this study there were 
positive relationships between Child score with 
elevated levels of Cystatin C. Additional samples 
were collected from similar studies in the future are 
expected to increase the strength of the relationship 
between the severity score of cirrhosis (Child score) 
with decreased renal function (elevated levels of 
Cystatin C). Cystatin C is superior to the detection of 
kidney function than other tools.
REFERENCES 
1. Friedman, SL 1999. Hepatic fibrosis. In: Schiff 
ER, Sorrell MF, Maddrey WC, eds. Schiff's 
th Diseases of the Liver. 8 ed. Philadelphia, Pa: 
Lippincott-Raven .p.371-85. 
2. Anonymous. 2010. Statistics by Country for 
C h i r r o s i s  o f  t h e  L i v e r ,  
WrongDiagnosis_com.htm 
3. Lawrence, SF 2003. Liver Cirrhosis in: 
Lawrence M, Tierney Jr., Stephen J, McPhee, 
Maxine A Current Medical Diagnosis & 
Treatment, ed 42, by The Mc Graw Hill.p. 
4. Propst, A., Propst, T., Zangerl, G., Ofner, D., 
Judmaier, G., Vogel, W. 1995. Prognosis and life 
expectancy in chronic liver disease. Dig Dis Sci; 
40:1805-1815 
5. Azhari, G. 2006. Hepataorenal Syndrome. 
Mirror World Medical.150: 15-17 
6. Gines, A., Escorsell, Gines, P. 1993, incidence, 
predictive factors and prognosis of the 
hepatorenal syndrome in cirrhosis and ascites. 
Gastroenterology; 105:229-236. 
7. Elaine, Y., Florence, W., Elaine, Y. 2004. Renal 
dysfunction in Chirrosis: Diagnosis, Treatment, 
and Prevention. MedGen. 6 (4): 9 
8. Pika, MB, Nina, C. 2007. Human cystatin C, 
Turkisj J Biochemistry 32 (3); 95-103 
9. Amgad, E., Alaa, U.S., Hasam, AG 2004. Serum 
cystatin C: A Good Marker For Evaluation of 
glomerular filtration rate In Hepatorenal 
Syndrome. European J of General Medicine. 4: 
29 -35 
10. Seo, YS, Jung ES, Kim, JH, Yim, HJ, Yeon, JE, 
Nyun, KS, Kim, CD, Ryu, HS, Um, SH 2009. 
Serum cystatin C level is a good marker 
bprognostic in Patients with cirrhotic ascites and 
normal serum creatinin levels. LIVER int. 29 
(10): 1521-7 
11. Nisar, HS, Mohammed, U., Faiz, A., Osama, I., 
Kaukab, B. 2001. Association of Child-Pugh 
Class with Patterns of Mortality in Hepatitis C 
Virus Related Chronic Liver Disease. J. Rawal 
Med Coll. 5 (2): 65-7 
12. Renan, AGB, Carlos, JCs, Pedro, GM, Dora, 
MLP, Julio, GO, Victor, LP 2003. Frequency of 
antibodies against the hepatitis C virus in 
Patients with hepatic cirrhosis in Yucatan. 
Mexico, Salud Publica Mex. 45:346-350 
19
Correlation Between Child Pugh Score and Cystatin CVolume 1, Number 1, Juli 2011
Acta Interna - The Journal of Internal Medicine
13. James F., Ching LL, David B., Danny W., Tin-
Kin C., Man-Fung Y. 2008. Fibrosis and 
prevalence of cirrhosis in Chronic Hepatitis B: 
Implication for Treatment and Management. 
American J of Gastroenterology. 103 (6): 1421-
1426 
14. Blankson, A., Wiredu, EK, Gyasi, RK-, Adjei, 
A., Tettey, Y. 2005. Sero-prevalence of Hepatitis 
B and C viruses in cirrhosis of the liver in Accra-
Ghana. Ghana Med J. 39 (4): 132 -137 
15. Rainer, P., Woitas,, Birgit, SW 2000. Correlation 
of Serum Concentration of cystatin C and 
creatinine to inulin Clearance in Liver cirrhosis. 
Clinical Chemistry. 46: 712-715 
16. Takeuchi, M., Fukuda, Y., Nakano, I., Katano, Y., 
Hayakawa, T. 2001. Elevation of serum cystatin 
in Patients with chronic liver disease. Eur J 
Gastroenterol Hepatol. 13(8) :951-5 
17. Christopher, C., Armelle, PR, Dominique, W., 
Marie, G., Yves, C., Renee, EP, Robert, P. 2004. 
Biochemical markers of liver fibrosis and 
lymphocytic piecemeal necrosis in UDCA-
treated Patients with primary biliary chirrosis. 
Liver International. 24(3): 341-344 
18. Blake, JC, Sprengers, Grech P., McCormick, PA, 
McIntyre, N., Burroughs, AK 1990. Bleeding 
time in Patients with hepatic cirrhosis. British 
Medical J. 301: 120-125 
20
Deshinta Putri Mulya, et al
